Please login to the form below

Not currently logged in
Email:
Password:

Kymab

This page shows the latest Kymab news and features for those working in and with pharma, biotech and healthcare.

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

Keytruda windfall helps research charity invest. Kymab's HQ at the Babraham campus, Cambridge, UK. ... LifeArc is to make an initial $10m equity investment in Kymab, with a further $20m to follow.

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    Dr Quaratino said: “Kymab’s emerging human antibody pipeline provides great potential to improve patient treatment options in our four main therapeutics areas of focus.". ... Dr David Chiswell, CEO of Kymab, said: “I am delighted to welcome Sonia

  • Dr Arndt Schottelius to lead Kymab’s R&D Dr Arndt Schottelius to lead Kymab’s R&D

    Cambridge, UK-based Kymab has appointed Dr Arndt Schottelius to the newly-created position of executive vice president of research and development. ... Dr David Chiswell, chief executive of Kymab, said: “I am delighted to welcome Dr Schottelius to the

  • Dr David Chiswell joins Kymab Dr David Chiswell joins Kymab

    Dr Chiswell said: “I have spent one of the most satisfying years of my career as interim CEO working closely with the excellent team at Kymab. ... I believe Kymab has all the tools needed to enable it to become a truly successful major biotech company.

  • Kymab names Anne Hyland as chief financial officer Kymab names Anne Hyland as chief financial officer

    Commenting on her appointment, Hyland said: “I am delighted to join Kymab at this exciting time. ... Anne's strong skill set will be invaluable as we build Kymab into a substantial global biopharmaceutical company.”.

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics